I am staring a start-up company that will be the first one stop-shop innovative bioformulation and bioprocessing hub in USA to be located in NC/RTP area that transforms biological business from lab and Research scale to Commercial scale, making biotech companies getting to monetization faster! At Fafabiotics, our mission is to develop innovative bioformulation solutions for as many new probiotics as possible and have an impact on improving people's lives.
We are hoping to become a B2B development company focusing on developing cost-effective, scale-able and high quality bioformulation/bioprocessing supporting companies in biotechnology with providing them bioformulation recipe and processes fitted to their active ingredient and application.
The following are some data reported by Precedence Research relate to market size for biotech:
· “ The global biotechnology market size was estimated at USD 1.37 trillion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 13.96% from 2023 to 2030. The market is driven by a strong government support through initiatives aimed at modernization of regulatory framework, improvements in approval processes & reimbursement policies, as well as standardization of clinical studies.”
· When it comes to biological market, its forecasted to grow at compound annual growth rate of 7.8% reaching 615.47 Billion by 2030. However, sensitivity of biological to heat, light and need for cold chain can hinder the growth.
o Within that, according to Precedence Research, the probiotics market size is predicted to reach around US$ 133.92 billion by 2030, with CAGR of ~ 8%. Probiotic cosmetic is part of that market and north America is expected to increase the demand for that market 3x from 2020 to 2030.
· “The global precision fermentation market size was valued at USD 1.93 billion in 2022 and is projected to hit around USD 63.85 billion by 2032, growing at a CAGR of 41.89% over the forecast period 2023 to 2032.”
· “The global single cell oil market size was estimated at USD 74.19 billion in 2022 and is projected to hit around USD 726.4 billion by 2032, poised to grow at a CAGR of 25.62% during the forecast period from 2023 to 2032”
·
These are just few examples of market demand and growth for biological material. However, without having stable and scale-able formulation that will create robust bioprocessing executable at large scale biomanufacturing and bioformulation that will ensure stability of the active ingredient from manufacturing to customer without significantly hassle of special handling.
Fafabiotics will be the first one-stop shop scientific and applied bioformulation hub supporting all vertices. Biotech companies in their early research would be the best costumer as we would be able to work with them early on and help them get to biomanufacturing step faster and with higher success rate.
Initially, we would target sectors with less regulatory needs to get to the market and gain customer’s trust faster. For that, during the first year Fafabiotics will focus on generating stable and scale-able bioformulation as probiotics for cosmetic and skin care and then will capture the market and customers from other vertices too. We would also initially target start-ups in their early research where they are restricted by time and competency to build their own bioformulation team.
We are going to charge $1M to $5M per bioformulation development per product bioformulation recipe and process development. We are also going to ask for 5% of the profit if the product we made the formulation for hits the market. It will take about 3 years once the full funding is available to fully build and execute the hub and once completed, will accept up to 20 customers per year for the first 3 years post establishment of labs and the hubs and then will increase to 100 customer per year. To build the hub from ground up and have all units and right people hired, we need $150M. We are expecting to have $500M revenue per year from year 3 to 6 and then get to billion revenue post year 6 as we capture more customers and also launch our own product in skincare.
Right now the main member of Fafabiotics is an expert in developing bioformulation and bioprocessing for biologicals with track record of creating functions and teams fast, create bioformulation targeted and in short time, has launched 5 biological products in 5 years in startup and optimized 2 biological formulation in less than 2 years in multinational are among accomplishments of the leader of this company! Furthermore, the leader has network of right competencies to hire once the funding is secure.
In order to show the proof of concept, starting with probiotic in skincare bioformulation, and make the ground work ahead of building a hub, I am asking for $550K for one year. That funding would cover salary and fringe at 40% of time, cost of working with few labs to test the concept, create the bioformulation and also start some toxicology testing.
I hope you consider investing in my company!
Farzaneh Rezaei, PhD.
FafaBiotic LLC, Founder and CEO
Cell: 919928633
NC 27518-9122
Ready to Ask For Funding for your company?
Post a Funding Request